Added to YB: 2025-07-22
Pitch date: 2025-07-19
FBIO [neutral]
Fortress Biotech, Inc.
+47.98%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
Market Cap
$58.3M
Pitch Price
$1.98
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.64
P/E
-0.90
EV/Sales
0.89
Sector
Biotechnology
Category
special_situation
Show full summary:
Fortress Biotech - Sold shares in FBIOP after CAEL-101 fails to reach primary endpoint in P3
FBIO (sell): Sold shares after CAEL-101 P3 failure, negative for FBIOP preferred stock as approval would've provided $19.6M for reinstated dividends in 2025-26. Increases pressure on CUTX-101 and its potential PRV as remaining lifeline.
Read full article (1 min)